IGFBP2 and schizophrenia: At the phenotypic level, 15q11.2 BP1-BP2 deletion carriers have an increased risk for schizophrenia [34] and learning difficulties, such as dyslexia and dyscalculia [35], as well as lower cognitive functioning [24, 25].